Mary Ciechoski
Adult Health · Buffalo, NYNPI 1740245992
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $150,978 of the $199,779 with a category attached, or 75.6%. 38 manufacturers reported payments, led by AbbVie at 35.4% of the total. Among adult health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,477 payments — averaging $135.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$71K
- Johnson & Johnson$29K
- Intercept Pharmaceuticals, Inc.$20K
- Phathom Pharmaceuticals, Inc.$18K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$15K
- Gilead$10K
- plus $38K from 32 others
What the payments were for
- Consulting fees$9,1705%
- Speaking & faculty fees$150,97876%
- Travel & lodging$9,6055%
- Food & beverage$29,64815%
- Education$3780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$199,779 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 42 | $1,132,618 |
| OcalivaObeticholic Acid | 48 | $515,860 |
| Humira(Cf) PenAdalimumab | 24 | $274,675 |
| XifaxanRifaximin | 84 | $256,881 |
| LinzessLinaclotide | 209 | $244,407 |
| Skyrizi On-BodyRisankizumab-Rzaa | 11 | $229,130 |
| RinvoqUpadacitinib | 29 | $198,065 |
| ZenpepLipase/Protease/Amylase | 23 | $191,489 |
| CreonLipase/Protease/Amylase | 44 | $177,336 |
| Mesalamine | 105 | $125,118 |
| Dupixent PenDupilumab | 12 | $93,114 |
| Budesonide ErBudesonide | 28 | $30,862 |
| Alosetron Hcl | 35 | $28,117 |
| Omeprazole | 997 | $19,534 |
| Famotidine | 716 | $18,768 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $29,323 | $1,132,61842 claims |
| AbbVieLinzess, Rinvoq, Creon | $70,659 | $619,808282 claims |
| Intercept Pharmaceuticals, Inc.Ocaliva | $19,503 | $515,86048 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $15,269 | $275,46597 claims |
| Aimmune Therapeutics, Inc.Zenpep | $154 | $191,48923 claims |
| SandozLansoprazole | $87 | $10,72973 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $247 | $3,94922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.
Other adult health in Buffalo
- Rosemary HansenBuffalo$40K
- Susan DemarcoBuffalo$20K
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Jennifer FioriniGlens Falls$151K
- Katelyn McCormackAmherst$131K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
- Alyson HartyNew York$65K
- Danielle BrunoPlainview$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.